Yun-Cheng Lv

2.4k total citations
49 papers, 1.6k citations indexed

About

Yun-Cheng Lv is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Yun-Cheng Lv has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 26 papers in Surgery and 17 papers in Cancer Research. Recurrent topics in Yun-Cheng Lv's work include Cholesterol and Lipid Metabolism (16 papers), MicroRNA in disease regulation (11 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Yun-Cheng Lv is often cited by papers focused on Cholesterol and Lipid Metabolism (16 papers), MicroRNA in disease regulation (11 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Yun-Cheng Lv collaborates with scholars based in China, Canada and United States. Yun-Cheng Lv's co-authors include Chao‐Ke Tang, Tianhong Peng, Xin-Ping Ouyang, Xi‐Long Zheng, Wei Xie, Pingping He, Feng Yao, Yang Zhou, Kai Yin and Dawei Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Yun-Cheng Lv

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun-Cheng Lv China 26 873 575 508 303 165 49 1.6k
Hong Jin China 21 557 0.6× 306 0.5× 432 0.9× 286 0.9× 186 1.1× 74 1.7k
Takafumi Senokuchi Japan 23 825 0.9× 212 0.4× 441 0.9× 385 1.3× 365 2.2× 42 1.7k
Songqing He China 30 1.2k 1.4× 622 1.1× 325 0.6× 333 1.1× 440 2.7× 108 2.4k
Liang Wen China 21 752 0.9× 231 0.4× 192 0.4× 304 1.0× 158 1.0× 54 1.4k
Zhe Meng China 20 505 0.6× 322 0.6× 150 0.3× 164 0.5× 110 0.7× 56 1.3k
Miaomiao Fan China 23 919 1.1× 250 0.4× 223 0.4× 172 0.6× 378 2.3× 42 1.7k
Ying Yu China 23 412 0.5× 215 0.4× 229 0.5× 244 0.8× 211 1.3× 50 1.5k
Lei Sun China 21 744 0.9× 220 0.4× 180 0.4× 137 0.5× 149 0.9× 70 1.4k

Countries citing papers authored by Yun-Cheng Lv

Since Specialization
Citations

This map shows the geographic impact of Yun-Cheng Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun-Cheng Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun-Cheng Lv more than expected).

Fields of papers citing papers by Yun-Cheng Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun-Cheng Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun-Cheng Lv. The network helps show where Yun-Cheng Lv may publish in the future.

Co-authorship network of co-authors of Yun-Cheng Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Yun-Cheng Lv. A scholar is included among the top collaborators of Yun-Cheng Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun-Cheng Lv. Yun-Cheng Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shirui, et al.. (2024). m6A RNA Methylation and Implications for Hepatic Lipid Metabolism. DNA and Cell Biology. 43(6). 271–278. 7 indexed citations
2.
Chen, Shirui, et al.. (2023). Sortilin-induced lipid accumulation and atherogenesis are suppressed by HNF1b SUMOylation promoted by flavone of Polygonatum odoratum. Journal of Zhejiang University SCIENCE B. 24(11). 998–1013. 1 indexed citations
3.
Ma, Qiang, et al.. (2022). N6‐methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis. Journal of Cellular Physiology. 237(7). 2729–2739. 12 indexed citations
5.
Liu, Fang, et al.. (2021). Transcriptional control by HNF-1: Emerging evidence showing its role in lipid metabolism and lipid metabolism disorders. Genes & Diseases. 9(5). 1248–1257. 31 indexed citations
6.
Chen, Jiaojiao, Jun Tao, Xiaolei Zhang, et al.. (2020). Inhibition of the ox-LDL-Induced Pyroptosis by FGF21 of Human Umbilical Vein Endothelial Cells Through the TET2-UQCRC1-ROS Pathway. DNA and Cell Biology. 39(4). 661–670. 31 indexed citations
8.
Wu, Li, Yun-Cheng Lv, Ying Lv, et al.. (2020). A novel secretagogin/ATF4 pathway is involved in oxidized LDL-induced endoplasmic reticulum stress and islet β-cell apoptosis. Acta Biochimica et Biophysica Sinica. 53(1). 54–62. 6 indexed citations
9.
Yang, Jing, et al.. (2019). Complicated trafficking behaviors involved in paradoxical regulation of sortilin in lipid metabolism. Journal of Cellular Physiology. 235(4). 3258–3269. 6 indexed citations
10.
Liu, Chuhao, Liang Li, Dongming Guo, et al.. (2018). Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism. Clinica Chimica Acta. 487. 33–40. 15 indexed citations
11.
Gao, Anbo, Francisco S. Cayabyab, Xi Chen, et al.. (2017). Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases. DNA and Cell Biology. 36(12). 1050–1061. 31 indexed citations
12.
Jiang, Ting, Kun Ren, Qian Chen, et al.. (2017). Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner. Cellular Physiology and Biochemistry. 43(4). 1703–1717. 64 indexed citations
13.
Cayabyab, Francisco S., et al.. (2016). Sortilin: A novel regulator in lipid metabolism and atherogenesis. Clinica Chimica Acta. 460. 11–17. 36 indexed citations
14.
He, Pingping, Xin-Ping Ouyang, Yuan Li, et al.. (2015). MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice. PLoS ONE. 10(9). e0138788–e0138788. 32 indexed citations
15.
Kuang, Peng, Lu-Shan Liu, Dangheng Wei, et al.. (2015). P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation. International Journal of Molecular Medicine. 35(5). 1179–1188. 110 indexed citations
16.
Yao, Feng, Yun-Cheng Lv, Min Zhang, et al.. (2015). Apelin-13 impedes foam cell formation by activating Class III PI3K/Beclin-1-mediated autophagic pathway. Biochemical and Biophysical Research Communications. 466(4). 637–643. 50 indexed citations
17.
Zhao, Guo-Jun, Zhongcheng Mo, Shilin Tang, et al.. (2014). Chlamydia pneumoniae negatively regulates ABCA1 expression via TLR2-Nuclear factor-kappa B and miR-33 pathways in THP-1 macrophage-derived foam cells. Atherosclerosis. 235(2). 519–525. 49 indexed citations
18.
Lv, Yun-Cheng, Kai Yin, Yuchang Fu, et al.. (2013). Posttranscriptional Regulation of ATP-Binding Cassette Transporter A1 in Lipid Metabolism. DNA and Cell Biology. 32(7). 348–358. 31 indexed citations
19.
Tian, Guo-Ping, Wujun Chen, Pingping He, et al.. (2012). MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie. 94(12). 2749–2755. 41 indexed citations
20.
Liu, Xiaoyan, Xin-Ping Ouyang, Shilin Tang, et al.. (2012). Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C α signaling in THP-1 macrophage-derived foam cells. Atherosclerosis. 226(2). 398–407. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026